|
|
Volumn 15, Issue 8, 2016, Pages 521-522
|
|
DNA vaccines against Zika virus speed into clinical trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA VACCINE;
GLS 5700;
MESSENGER RNA;
NANOPARTICLE;
UNCLASSIFIED DRUG;
VIRUS ANTIGEN;
VIRUS DNA;
VIRUS PROTEIN;
VIRUS VACCINE;
ANTIGEN PRESENTING CELL;
CELL MEMBRANE;
CELL NUCLEUS;
DRUG EFFICACY;
DRUG SAFETY;
GENE DELIVERY SYSTEM;
GENETIC ANALYSIS;
GENETIC CODE;
HUMAN;
IMMUNE RESPONSE;
MICROCEPHALY;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PLASMID;
PRIORITY JOURNAL;
RNA INTERFERENCE;
SHORT SURVEY;
VIRUS STRAIN;
VIRUS TRANSMISSION;
ZIKA FEVER;
ZIKA VIRUS;
CLINICAL TRIAL (TOPIC);
IMMUNOLOGY;
ZIKA VIRUS INFECTION;
CLINICAL TRIALS AS TOPIC;
CLINICAL TRIALS, PHASE I AS TOPIC;
HUMANS;
VACCINES, DNA;
VIRAL VACCINES;
ZIKA VIRUS;
ZIKA VIRUS INFECTION;
|
|
EID: 84979992307
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.159 Document Type: Short Survey |
|
Times cited : (31)
|
|
References (0)
|
